文献速递药物不良反应与药物警戒

人工智能与药物安全专业人员的未来

Artificial Intelligence and the Future of the Drug Safety Professional.
PubMed 文献 · Drug Saf · 2019-01-01

本文讨论药物警戒领域数据量增长背景下人工智能(AI)辅助技术的应用前景,并介绍Celgene全球药物安全与风险管理团队开展的一项访谈研究:对6名药物安全专业人员的12部分问卷调查显示,受访者整体对AI提升工作角色持热情态度,认为AI可将药物警戒工作从数量导向转向价值导向。

要点

  • 药物警戒需借助AI规模化辅助以应对个体病例安全报告数据增长。
  • 受访药物安全专业人员对AI改变工作角色整体持热情态度。
  • AI有望将药物警戒资源从数量导向转向价值导向。

核心结论

  • AI在药物警戒领域的应用可能改变药物安全专业人员的日常工作与职业发展。
  • 受访药物安全专业人员整体对AI增强下的角色变化持热情态度。
  • 受访者认为AI可使药物警戒资源、时间与技能从数量导向转向价值导向。
  • 机器学习算法有潜力增强药物安全专业人员的决策过程并支持更高效准确的病例处理。

研究设计与样本

  • Celgene全球药物安全与风险管理团队开展的研究,采用基于12部分问卷的访谈。
  • 样本为6名代表药物警戒运营不同领域的药物安全专业人员。
  • 访谈问题涵盖受访者背景、当前角色与未来期望。
  • 研究结果以对访谈问题的汇总回答形式呈现。

主要发现

  • 受访药物安全专业人员整体对AI增强下工作角色可能变化持热情态度。
  • 受访者建议AI可使药物警戒资源、时间与技能从数量导向转向价值导向。
  • 结果提示药物警戒专业人员希望将资质、技能与经验用于更有价值的工作。
  • 机器学习算法有潜力增强决策过程并支持更高效准确的病例处理。

临床怎么用

  • 药物警戒团队可考虑规模化引入AI辅助技术以应对个体病例安全报告数据增长。
  • 药物安全专业人员可关注AI辅助下的角色转变与技能需求变化。

局限性

  • 访谈样本仅6名药物安全专业人员,结果以汇总回答形式呈现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The healthcare industry, and specifically the pharmacovigilance industry, recognizes the need to support the increasing amount of data received from individual case safety reports (ICSRs). To cope with this increase, more healthcare and qualified professionals are required to capture and evaluate the data. To address the evolving landscape, it will be necessary to embrace assistive technologies such as artificial intelligence (AI) at scale. AI in the field of pharmacovigilance will possibly result in the transformation of the drug safety (DS) professional's daily work life and their career development. Celgene's Global Drug Safety and Risk Management (GDSRM) function has established a series of work activities to drive innovation across the pharmacovigilance value chain (Celgene Chrysalis Fact Sheet. https://www.celgene.com/newsroom/media-library/chrysalis-fact-sheet/, 2018). The development of AI in pharmacovigilance raises questions about the possible changes in DS professionals' lives, who may find themselves curious about their future roles in a workplace assisted by AI. We discuss the current state of pharmacovigilance and the DS professional, AI in pharmacovigilance and the potential skillsets a DS professional may require when working with AI. We also describe the results of research conducted at Celgene GDSRM. The objective of the research was to understand the thoughts of pharmacovigilance professionals about their jobs. These results are provided in the form of aggregated responses to interview questions based on a 12-part questionnaire [see the Electronic Supplementary Material (ESM)]. A sample of six DS professionals representing various areas of pharmacovigilance operations were asked a range of questions about their backgrounds, current roles and future expectations. The DS professionals interviewed were, overall, enthusiastic about their job roles potentially changing with AI enhancements. Interviewees suggested that AI would allow for pharmacovigilance resources, time, and skills to shift the work from a volume-based to a value-based focus. The results suggest that pharmacovigilance professionals wish to use their qualifications, skillsets and experience in work that provides more value for their efforts. Machine learning algorithms have the potential to enhance DS professionals' decision-making processes and support more efficient and accurate case processing.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Danysz K, Cicirello S, Mingle E, et al. Artificial Intelligence and the Future of the Drug Safety Professional. Drug Saf. 2019. PMID: 30343417. doi:10.1007/s40264-018-0746-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。